Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Maha H. A. Hussain
Based on 71 articles published since 2008
||||
Expertise Level
The expertise of Maha H. A. Hussain ranks in the
  • Top 0.04%
  • ... of 129,687 published authors worldwide on Prostatic Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 71 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Hussain, Maha H   ·   Hussain, Maha   ·   Hussain, Maha H A
Work Locations
Details
Most likely:    Northwestern University   Contact    
2018
  • From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago (M.H.), and Astellas Pharma, Northbrook (D.P., A.K.) - both in Illinois · Institut Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.) · the University of Montreal Hospital Center, Montreal (F.S.) · Herlev Hospital, Herlev, Denmark (P.R.) · Carolina Urologic Research Center, Myrtle Beach, SC (N.S.) · State University of Campinas (Unicamp), Campinas, Brazil (U.F.) · Kiev City Clinical Hospital 3, Kiev, Ukraine (P.I.) · Pfizer, San Francisco (E.D., K.M.) · and the Department of Medical Oncology, San Camillo Forlanini Hospital, Rome (C.N.S.). · Pubmed 29949494
  • Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Medical Oncology, University of Washington, Seattle, Washington. · Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. · US Oncology, Las Vegas, Nevada. · Northwestern University, Feinberg School of Medicine, Chicago, Illinois. · CHRISTUS Santa Rosa Medical Center Hospital, San Antonio, Texas. · Departments of Internal Medicine and Biomedical Engineering, Center for Computational Medicine and Bioinformatics, Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan. · Pubmed 29105802
  • Robert H. Lurie Comprehensive Cancer Center, Chicago, IL · University of Montreal Hospital Center, Montreal, QC, Canada · San Camillo Forlanini Hospital, Rome, Italy · Pubmed 30281993
2017
  • Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. · Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. · Pubmed 28323334
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois. · Pubmed 29040256
2017
  • aRobert H. Lurie Comprehensive Cancer Center bNorthwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Pubmed 28825922
2016
  • From the *Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI; and †Division of Hematology Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. · Pubmed 27749325
2013
  • Division of Hematology/Oncology, Department of Internal Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Pubmed 23511665
Probable:    University of Michigan   Contact    
2017
  • Division of Medical Oncology, University of Colorado, School of Medicine, University of Colorado Cancer Center, Aurora. · Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Departments of Medicine and Urology, University of Michigan Comprehensive Cancer Center, Ann Arbor. · Department of Medicine, Huntsman Cancer Institute at the University of Utah, Salt Lake City. · Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas. · Department of Medicine, Yale Cancer Center, New Haven, Connecticut. · Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. · Department of Urology, The University of Texas Health Science Center at San Antonio. · Pubmed 28358937
  • University of Alabama at Birmingham, Birmingham, AL. Electronic address: · McMaster University, Hamilton, ON, Canada. · SWOG Statistical Center, Seattle, WA. · University of Michigan, Ann Arbor, MI. · UC Davis Cancer Center, Sacramento, CA. · University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA. · Oregon Health & Science University, Portland, OR. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · University of Texas Health Science Center at San Antonio, San Antonio, TX. · City of Hope Medical Center, Duarte, CA. · University of Kansas, Kansas City, KS. · University of Utah, Salt Lake City, UT. · Johns Hopkins Kimmel Cancer Center, Baltimore, MD. · Ohio State University, Columbus, OH. · Pubmed 28579151
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · David Nanus, NewYork Presbyterian Weill Cornell Medical Center · Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY · Walter M. Stadler, University of Chicago Medicine, Chicago, IL · Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA · Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC · Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD · Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX · Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA · Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC · Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit · and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA · Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI · Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ · Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Oliver Sartor, Tulane School of Medicine, New Orleans, LA · Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School · Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • University of Michigan, Ann Arbor, Michigan. · Service d'Oncologie médicale, Hôpital du Val-de-Grâce, Paris, France. · Merck KGaA, Darmstadt, Germany. · Department of Urology, Charité, Berlin, Germany. · Pubmed 26839144
  • Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Catherine Tangen, SWOG Statistical Center · Celestia Higano, University of Washington, Seattle, WA · Nicholas Vogelzang, US Oncology, Las Vegas, NV · and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Pubmed 26552421
  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ. · University of Michigan, Ann Arbor, MI. · University of Chicago, Chicago, IL. · UW Carbone Cancer Center, University of Wisconsin, Madison, WI. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ. Electronic address: · Pubmed 26476589
  • Departments of Internal Medicine and Urology, University of Michigan, Ann Arbor. · Johns Hopkins Sidney Kimmel Cancer Center, Oncology, Baltimore, Maryland. · Pubmed 27560843
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle · the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.) · Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York · the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.) · Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.) · and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC · William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA · Haojin Zhou, Merck, Beijing, China · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Catherine M. Tangen, Southwest Oncology Group Statistical Center · Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia · Daniel P. Petrylak, Yale Cancer Center, New Haven, CT · Maha Hussain, University of Michigan, Ann Arbor, MI · Nicholas J. Vogelzang, US Oncology, Las Vegas, NV · Ian M. Thompson, University of Texas at San Antonio, San Antonio · John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX · Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia · Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada · Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom · Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD · Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ · David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles · Eric J. Small, University of California San Francisco, San Francisco, CA · Celestia S. Higano, University of Washington, Seattle, WA · and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
  • Columbia University Medical Center, New York, New York. · Fred Hutchinson Cancer Research Center, Seattle, Washington. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Knight Cancer Institute, Oregon Health and Science University, Portland. · Cancer Therapy and Research Center, San Antonio, Texas. · University of Michigan Comprehensive Cancer Center, Ann Arbor. · Pubmed 26720308
2015
  • Division of Hematology/Oncology, Department of Internal Medicine and University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Pubmed 25832592
  • Department of Urologic Oncology, School of Medicine, University of Colorado Denver, Aurora, Colorado. Electronic address: · Division of Medical Oncology, Department of Medicine and Department of Urology, School of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Smilow Cancer Center, Yale University, New Haven, Connecticut. · Pubmed 26196735
  • From the University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ. · Pubmed 25993136
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States. Electronic address: · Memorial Sloan-Kettering, New York, NY, United States. · University of Wisconsin, Carbone Cancer Center, Madison, WI, United States. · Duke Cancer Institute and Duke Prostate Center, Duke University, Durham, NC, United States. · Thomas Jefferson University, Philadelphia, PA, United States. · New York University Clinical Cancer Center, New York, NY, United States. · Sarah Cannon Research Institute, Nashville, TN, United States. · Eli Lilly and Company, Bridgewater, NJ, United States. · Eli Lilly and Company, Indianapolis, IN, United States. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, United States. · Pubmed 26082390
  • Department of Radiology, University of Michigan, Ann Arbor, Michigan, United States of America. · Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, United States of America. · Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, United States of America. · Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, United States of America. · Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. · Pubmed 25859981
  • From the Department of Medicine (C.J.S.) and the Department of Biostatistics and Computational Biology (Y.-H.C.), Dana-Farber Cancer Institute, Boston · Harvard Medical School, Boston (C.J.S.) · Johns Hopkins University, Baltimore (M.C., M.E.) · University of Wisconsin Carbone Cancer Center (G.L., D.F.J.) and School of Medicine and Public Health (D.F.J.), Madison · Fox Chase Cancer Center, Temple University Health System, Philadelphia (Y.-N.W.) · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis (N.H.) · Mayo Clinic, Rochester, MN (M.K.) · University Hospitals Case Medical Center, Seidman Cancer Center (M.M.C.), and Cleveland Clinic Taussig Cancer Institute (J.A.G.) - both in Cleveland · University of Virginia Cancer Center, Charlottesville (R.D.) · Comprehensive Cancer Centers of Nevada, Las Vegas (N.J.V.) · Siteman Cancer Center, Washington University School of Medicine, St. Louis (J.P.) · NorthShore University HealthSystem, Evanston, IL (D.S.) · University of Michigan Comprehensive Cancer Center, Ann Arbor (M.H.) · and Rutgers Cancer Institute of New Jersey, New Brunswick (R.S.D.). · Pubmed 26244877
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • From the Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Pubmed 25993184
2014
  • Matthew R. Smith, Massachusettes General Hospital · Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA · Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX · Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY · David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI · Daniel J. George, Duke University Medical Center, Durham · Ethan M. Basch, University of North Carolina, Chapel Hill, NC · Celestia S. Higano, University of Washington, Seattle, WA · Andrea L. Harzstark, University of California San Francisco, San Francisco · Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA · A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ · Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; · MD Anderson Cancer Center, Houston, Texas; · Massachusetts General Hospital Cancer Center, Boston; · Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland; · Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon; · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; · University of Wisconsin Carbone Cancer Center, Madison, Wisconsin; and. · Takeda Pharmaceuticals International Co.; · Millennium: The Takeda Oncology Company, Cambridge, Massachusetts; · Duke University Medical Center, Durham, North Carolina. · Pubmed 24965748
  • Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA, · Pubmed 24764124
  • Amir Goldkorn, David I. Quinn, and Tong Xu, University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles · Przemyslaw Twardowski, City of Hope, Duarte · Philip C. Mack and Primo Lara Jr, University of California, Davis, Sacramento, CA · Benjamin Ely and Catherine M. Tangen, Southwest Oncology Group Statistical Center · Celestia S. Higano, Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, and University of Washington, Seattle, WA · Louis M. Fink, Nevada Cancer Institute · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada and US Oncology Research, Las Vegas, NV · Peter J. Van Veldhuizen, University of Kansas Cancer Center, Westwood, KS · Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT · Michael A. Carducci, Johns Hopkins Kimmel Cancer Center and Eastern Cooperative Oncology Group, Baltimore, MD · J. Paul Monk III, Ohio State University and Cancer and Leukemia Group B, Columbus, OH · Ram H. Datar and Richard J. Cote, University of Miami Miller School of Medicine, Miami, FL · Mark Garzotto, Portland Veterans Affairs Medical Center, Portland, OR · Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · and Ian Murchie Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 24616308
  • Affiliations of authors: University of California Davis Comprehensive Cancer Center, Sacramento, CA (PNL, PCM) · Southwest Oncology Group Statistical Center, Seattle, WA (BE, CT) · University of Southern California Norris Cancer Center, Los Angeles, CA (DIQ, AG) · USDA Western Human Nutrition Center at University of California Davis, Davis, CA (EG, MVL) · City of Hope, Duarte, CA (PT) · University of Michigan, Ann Arbor, MI (MH), US Oncology, Las Vegas, NV (NJV) · Cancer Treatment and Research Center, University of Texas, San Antonio, TX (IT). · Pubmed 24565955
2013
  • University of Michigan, Division of Hematology/Oncology, 1500 E Medical Center Dr., 7314 CC, Ann Arbor, MI 48109-0946, USA. · Pubmed 23550669
2009
2016
  • From the *Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI; and †Division of Hematology Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. · Pubmed 27749325
2015
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington · Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle · Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA · Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Sumanta K. Pal, City of Hope, Duarte · David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA · Ajjai Alva, University of Michigan, Ann Arbor · Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI · Elaine T. Lam, University of Colorado, Denver, CO · Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL · Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC · Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
2014
  • University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Room 7314, Ann Arbor, MI, 48109-5946, USA. · Pubmed 24395278
2013
  • Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI 48109-5946, USA. · Pubmed 23806498
  • Division of Hematology/Oncology, Department of Internal Medicine, and University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA. · Pubmed 23337753
  • Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI 48109, USA. · Pubmed 22705096
  • University of Michigan, Ann Arbor, MI, USA. · Pubmed 23169517
  • Department of Urology, The University of Michigan, Ann Arbor, MI 48109, USA. · Pubmed 23242739
2012
  • University of Michigan Comprehensive Cancer Center, 7314 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5946, USA. · Pubmed 21049281
2011
  • Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan 48109-5946, USA. · Pubmed 21717904
  • University of Michigan, Ann Arbor, Michigan 48109-5948, USA. · Pubmed 21334731
  • Michigan Center for Translational Pathology, University of Michigan, 1400 E. Medical Center Drive, 5316 CCGC, Ann Arbor, MI 48109, USA. · Pubmed 21575865
2009
  • Department of Medicine and Urology, University of Michigan, Ann Arbor, Michigan, USA. · Pubmed 19711464
2008
  • Genitourinary Oncology Service, Department of Medicine, Division of Hematology-Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA. · Pubmed 18593620
  • Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI 48109-0946, USA. · Pubmed 18303478
  • Division of Hematology and Oncology, Department of Medicine, University of Michigan School of Medicine and University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109-0946, USA. · Pubmed 18207190
Probable:    Rutgers University      
2015
  • From the University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ. · Pubmed 25993136
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 71 total) written by Maha H. A. Hussain about Prostatic Neoplasms:

  • Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer. 2018
  • Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer. 2018
  • Enzalutamide in Castration-Resistant Prostate Cancer. 2018
  • Risk stratification in oligometastatic prostate cancer: where are we and what do we need? 2017
  • The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies. 2017
  • Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction. 2017
  • The role of genomics in patients with advanced prostate cancer. 2017
  • Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421. 2017
  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. 2016
  • Androgen Receptor and Beyond, Targeting Androgen Signaling in Castration-Resistant Prostate Cancer. 2016
Show List of Full Article Records
Google Searches

Learn more about Maha H. A. Hussain using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Northwestern University
University of Michigan
Rutgers University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Northwestern University
2018
  • From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago (M.H.), and Astellas Pharma, Northbrook (D.P., A.K.) - both in Illinois · Institut Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.) · the University of Montreal Hospital Center, Montreal (F.S.) · Herlev Hospital, Herlev, Denmark (P.R.) · Carolina Urologic Research Center, Myrtle Beach, SC (N.S.) · State University of Campinas (Unicamp), Campinas, Brazil (U.F.) · Kiev City Clinical Hospital 3, Kiev, Ukraine (P.I.) · Pfizer, San Francisco (E.D., K.M.) · and the Department of Medical Oncology, San Camillo Forlanini Hospital, Rome (C.N.S.). · Pubmed 29949494
  • Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Medical Oncology, University of Washington, Seattle, Washington. · Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. · US Oncology, Las Vegas, Nevada. · Northwestern University, Feinberg School of Medicine, Chicago, Illinois. · CHRISTUS Santa Rosa Medical Center Hospital, San Antonio, Texas. · Departments of Internal Medicine and Biomedical Engineering, Center for Computational Medicine and Bioinformatics, Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan. · Pubmed 29105802
  • Robert H. Lurie Comprehensive Cancer Center, Chicago, IL · University of Montreal Hospital Center, Montreal, QC, Canada · San Camillo Forlanini Hospital, Rome, Italy · Pubmed 30281993
2017
  • Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. · Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland. · Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. · Pubmed 28323334
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois. · Pubmed 29040256
2017
  • aRobert H. Lurie Comprehensive Cancer Center bNorthwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Pubmed 28825922
2016
  • From the *Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI; and †Division of Hematology Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. · Pubmed 27749325
2013
  • Division of Hematology/Oncology, Department of Internal Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Pubmed 23511665
University of Michigan
2017
  • Division of Medical Oncology, University of Colorado, School of Medicine, University of Colorado Cancer Center, Aurora. · Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Departments of Medicine and Urology, University of Michigan Comprehensive Cancer Center, Ann Arbor. · Department of Medicine, Huntsman Cancer Institute at the University of Utah, Salt Lake City. · Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas. · Department of Medicine, Yale Cancer Center, New Haven, Connecticut. · Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. · Department of Urology, The University of Texas Health Science Center at San Antonio. · Pubmed 28358937
  • University of Alabama at Birmingham, Birmingham, AL. Electronic address: · McMaster University, Hamilton, ON, Canada. · SWOG Statistical Center, Seattle, WA. · University of Michigan, Ann Arbor, MI. · UC Davis Cancer Center, Sacramento, CA. · University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA. · Oregon Health & Science University, Portland, OR. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA. · Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · University of Texas Health Science Center at San Antonio, San Antonio, TX. · City of Hope Medical Center, Duarte, CA. · University of Kansas, Kansas City, KS. · University of Utah, Salt Lake City, UT. · Johns Hopkins Kimmel Cancer Center, Baltimore, MD. · Ohio State University, Columbus, OH. · Pubmed 28579151
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · David Nanus, NewYork Presbyterian Weill Cornell Medical Center · Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY · Walter M. Stadler, University of Chicago Medicine, Chicago, IL · Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA · Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC · Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD · Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX · Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA · Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC · Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit · and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA · Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI · Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ · Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Oliver Sartor, Tulane School of Medicine, New Orleans, LA · Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School · Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • University of Michigan, Ann Arbor, Michigan. · Service d'Oncologie médicale, Hôpital du Val-de-Grâce, Paris, France. · Merck KGaA, Darmstadt, Germany. · Department of Urology, Charité, Berlin, Germany. · Pubmed 26839144
  • Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Catherine Tangen, SWOG Statistical Center · Celestia Higano, University of Washington, Seattle, WA · Nicholas Vogelzang, US Oncology, Las Vegas, NV · and Ian Thompson, University of Texas Health Science Center, San Antonio, TX. · Pubmed 26552421
  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ. · University of Michigan, Ann Arbor, MI. · University of Chicago, Chicago, IL. · UW Carbone Cancer Center, University of Wisconsin, Madison, WI. · Rutgers Cancer Institute of New Jersey, New Brunswick, NJ. Electronic address: · Pubmed 26476589
  • Departments of Internal Medicine and Urology, University of Michigan, Ann Arbor. · Johns Hopkins Sidney Kimmel Cancer Center, Oncology, Baltimore, Maryland. · Pubmed 27560843
  • From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle · the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.) · Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York · the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.) · Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.) · and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.). · Pubmed 27433846
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC · William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA · Haojin Zhou, Merck, Beijing, China · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Catherine M. Tangen, Southwest Oncology Group Statistical Center · Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia · Daniel P. Petrylak, Yale Cancer Center, New Haven, CT · Maha Hussain, University of Michigan, Ann Arbor, MI · Nicholas J. Vogelzang, US Oncology, Las Vegas, NV · Ian M. Thompson, University of Texas at San Antonio, San Antonio · John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX · Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia · Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada · Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom · Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD · Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ · David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles · Eric J. Small, University of California San Francisco, San Francisco, CA · Celestia S. Higano, University of Washington, Seattle, WA · and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
  • Columbia University Medical Center, New York, New York. · Fred Hutchinson Cancer Research Center, Seattle, Washington. · SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Knight Cancer Institute, Oregon Health and Science University, Portland. · Cancer Therapy and Research Center, San Antonio, Texas. · University of Michigan Comprehensive Cancer Center, Ann Arbor. · Pubmed 26720308
2015
  • Division of Hematology/Oncology, Department of Internal Medicine and University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Pubmed 25832592
  • Department of Urologic Oncology, School of Medicine, University of Colorado Denver, Aurora, Colorado. Electronic address: · Division of Medical Oncology, Department of Medicine and Department of Urology, School of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Smilow Cancer Center, Yale University, New Haven, Connecticut. · Pubmed 26196735
  • From the University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ. · Pubmed 25993136
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States. Electronic address: · Memorial Sloan-Kettering, New York, NY, United States. · University of Wisconsin, Carbone Cancer Center, Madison, WI, United States. · Duke Cancer Institute and Duke Prostate Center, Duke University, Durham, NC, United States. · Thomas Jefferson University, Philadelphia, PA, United States. · New York University Clinical Cancer Center, New York, NY, United States. · Sarah Cannon Research Institute, Nashville, TN, United States. · Eli Lilly and Company, Bridgewater, NJ, United States. · Eli Lilly and Company, Indianapolis, IN, United States. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, United States. · Pubmed 26082390
  • Department of Radiology, University of Michigan, Ann Arbor, Michigan, United States of America. · Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, United States of America. · Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, United States of America. · Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, United States of America. · Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. · Pubmed 25859981
  • From the Department of Medicine (C.J.S.) and the Department of Biostatistics and Computational Biology (Y.-H.C.), Dana-Farber Cancer Institute, Boston · Harvard Medical School, Boston (C.J.S.) · Johns Hopkins University, Baltimore (M.C., M.E.) · University of Wisconsin Carbone Cancer Center (G.L., D.F.J.) and School of Medicine and Public Health (D.F.J.), Madison · Fox Chase Cancer Center, Temple University Health System, Philadelphia (Y.-N.W.) · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis (N.H.) · Mayo Clinic, Rochester, MN (M.K.) · University Hospitals Case Medical Center, Seidman Cancer Center (M.M.C.), and Cleveland Clinic Taussig Cancer Institute (J.A.G.) - both in Cleveland · University of Virginia Cancer Center, Charlottesville (R.D.) · Comprehensive Cancer Centers of Nevada, Las Vegas (N.J.V.) · Siteman Cancer Center, Washington University School of Medicine, St. Louis (J.P.) · NorthShore University HealthSystem, Evanston, IL (D.S.) · University of Michigan Comprehensive Cancer Center, Ann Arbor (M.H.) · and Rutgers Cancer Institute of New Jersey, New Brunswick (R.S.D.). · Pubmed 26244877
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • From the Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. · Pubmed 25993184
2014
  • Matthew R. Smith, Massachusettes General Hospital · Christopher J. Sweeney, Aymen Elfiky, Dana-Farber Cancer Institute, Boston, MA · Paul G. Corn, Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX · Dana E. Rathkopf, Howard I. Scher, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY · David C. Smith, Maha Hussain, University of Michigan, Ann Arbor, MI · Daniel J. George, Duke University Medical Center, Durham · Ethan M. Basch, University of North Carolina, Chapel Hill, NC · Celestia S. Higano, University of Washington, Seattle, WA · Andrea L. Harzstark, University of California San Francisco, San Francisco · Christian Scheffold, A. Douglas Laird, Frauke Schimmoller, Exelixis, South San Francisco, CA · A. Oliver Sartor, Tulane Cancer Center, Tulane University, New Orleans, LA · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ · Naomi B. Haas, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA · Johann S. de Bono, Royal Marsden Hospital, Sutton, Surrey, United Kingdom. · Pubmed 25225437
  • University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; · MD Anderson Cancer Center, Houston, Texas; · Massachusetts General Hospital Cancer Center, Boston; · Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland; · Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon; · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; · University of Wisconsin Carbone Cancer Center, Madison, Wisconsin; and. · Takeda Pharmaceuticals International Co.; · Millennium: The Takeda Oncology Company, Cambridge, Massachusetts; · Duke University Medical Center, Durham, North Carolina. · Pubmed 24965748
  • Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA, · Pubmed 24764124
  • Amir Goldkorn, David I. Quinn, and Tong Xu, University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles · Przemyslaw Twardowski, City of Hope, Duarte · Philip C. Mack and Primo Lara Jr, University of California, Davis, Sacramento, CA · Benjamin Ely and Catherine M. Tangen, Southwest Oncology Group Statistical Center · Celestia S. Higano, Puget Sound Oncology Consortium, Seattle Cancer Care Alliance, and University of Washington, Seattle, WA · Louis M. Fink, Nevada Cancer Institute · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada and US Oncology Research, Las Vegas, NV · Peter J. Van Veldhuizen, University of Kansas Cancer Center, Westwood, KS · Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT · Michael A. Carducci, Johns Hopkins Kimmel Cancer Center and Eastern Cooperative Oncology Group, Baltimore, MD · J. Paul Monk III, Ohio State University and Cancer and Leukemia Group B, Columbus, OH · Ram H. Datar and Richard J. Cote, University of Miami Miller School of Medicine, Miami, FL · Mark Garzotto, Portland Veterans Affairs Medical Center, Portland, OR · Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · and Ian Murchie Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 24616308
  • Affiliations of authors: University of California Davis Comprehensive Cancer Center, Sacramento, CA (PNL, PCM) · Southwest Oncology Group Statistical Center, Seattle, WA (BE, CT) · University of Southern California Norris Cancer Center, Los Angeles, CA (DIQ, AG) · USDA Western Human Nutrition Center at University of California Davis, Davis, CA (EG, MVL) · City of Hope, Duarte, CA (PT) · University of Michigan, Ann Arbor, MI (MH), US Oncology, Las Vegas, NV (NJV) · Cancer Treatment and Research Center, University of Texas, San Antonio, TX (IT). · Pubmed 24565955
2013
  • University of Michigan, Division of Hematology/Oncology, 1500 E Medical Center Dr., 7314 CC, Ann Arbor, MI 48109-0946, USA. · Pubmed 23550669
2009
2016
  • From the *Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI; and †Division of Hematology Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. · Pubmed 27749325
2015
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington · Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle · Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA · Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Sumanta K. Pal, City of Hope, Duarte · David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA · Ajjai Alva, University of Michigan, Ann Arbor · Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI · Elaine T. Lam, University of Colorado, Denver, CO · Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL · Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC · Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
2014
  • University of Michigan Comprehensive Cancer Center, 1500 East Medical Center Drive, Room 7314, Ann Arbor, MI, 48109-5946, USA. · Pubmed 24395278
2013
  • Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI 48109-5946, USA. · Pubmed 23806498
  • Division of Hematology/Oncology, Department of Internal Medicine, and University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA. · Pubmed 23337753
  • Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI 48109, USA. · Pubmed 22705096
  • University of Michigan, Ann Arbor, MI, USA. · Pubmed 23169517
  • Department of Urology, The University of Michigan, Ann Arbor, MI 48109, USA. · Pubmed 23242739
2012
  • University of Michigan Comprehensive Cancer Center, 7314 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5946, USA. · Pubmed 21049281
2011
  • Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan 48109-5946, USA. · Pubmed 21717904
  • University of Michigan, Ann Arbor, Michigan 48109-5948, USA. · Pubmed 21334731
  • Michigan Center for Translational Pathology, University of Michigan, 1400 E. Medical Center Drive, 5316 CCGC, Ann Arbor, MI 48109, USA. · Pubmed 21575865
2009
  • Department of Medicine and Urology, University of Michigan, Ann Arbor, Michigan, USA. · Pubmed 19711464
2008
  • Genitourinary Oncology Service, Department of Medicine, Division of Hematology-Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109, USA. · Pubmed 18593620
  • Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI 48109-0946, USA. · Pubmed 18303478
  • Division of Hematology and Oncology, Department of Medicine, University of Michigan School of Medicine and University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109-0946, USA. · Pubmed 18207190
Rutgers University
2015
  • From the University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ. · Pubmed 25993136
25 Other Locations Show
Yearly article counts 35101061137169
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.